← Back
Data updated: Mar 10, 2026
MORPHOSYS US INC
Oncology
MORPHOSYS US INC is a biotechnology company focused on Oncology.
2020
Since
1
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2020-07-31
- Latest
- 2025-06-18
- Applications
- 1